VI Ventures Overview
- Investor Type
-
Venture Capital
- Status
-
Active
- Professionals
-
8
- Investments
-
56
- Portfolio
-
33
- Exits
-
16
VI Ventures General Information
Company Description
VI Ventures is a venture capital firm that seeks to invest in the Medtech and Technology, Media and Telecommunications sectors. The firm prefers to invest in companies based in the United States, China and Israel. VI Ventures has offices in Hong Kong, Shenzhen and Shanghai.
Business Details
Website
www.en.vi-ventures.comInvestor Status
Primary Investor Type
Corporate Office
- 19F, Two International Finance Centre
- Central
- Hong Kong
- Hong Kong
VI Ventures Investments (56)
| Company Name | Deal Date | Deal Type | Deal Size | Industry | Company Stage | Lead Partner |
|---|---|---|---|---|---|---|
| AxCel Technology | 01-Mar-2023 | Later Stage VC | Network Management Software | Generating Revenue | ||
| Metagenomi | 05-Jan-2023 | Drug Discovery | Generating Revenue/Not Profitable | |||
| Biovision Biomedical Technology | 10-Aug-2022 | Biotechnology | Clinical Trials - General | |||
| WhiteSwell | 24-Jun-2022 | Therapeutic Devices | Generating Revenue | |||
| Design Pharma | 12-Apr-2022 | Drug Discovery | Generating Revenue | |||
| ACXEL | 16-Nov-2021 | Application Specific Semiconductors | Generating Revenue | |||
| Base Therapeutics | 26-Jul-2021 | Biotechnology | Generating Revenue | |||
| Tyligand Bioscience | 20-May-2021 | Drug Discovery | Clinical Trials - General | |||
| Fresh Wind Biotechnologies | 13-Nov-2020 | Early Stage VC | Biotechnology | Startup | ||
| Yizhen Intelligence | 19-Aug-2020 | Early Stage VC | Practice Management (Healthcare) | Generating Revenue |
VI Ventures Exits (16)
| Company Name | Exit Date | Exit Type | Exit Size |
|---|---|---|---|
| HaoStay | 27-May-2024 | Out of Business | |
| Metagenomi | 09-Feb-2024 | ||
| PlateletBio | 02-Dec-2023 | ||
| Applied StemCell | 09-Oct-2023 | ||
| Apexigen | 01-Aug-2022 | ||
| IceCure Medical | 10-Dec-2021 | ||
| Aadi Bioscience | 26-Aug-2021 | ||
| Rani Therapeutics | 30-Jul-2021 | ||
| Vocalis Health | 01-Apr-2021 | Out of Business | |
| Viracta Therapeutics | 24-Feb-2021 | Reverse Merger |
VI Ventures Investments by Industry, Year, and Region
Investments by Industry
Investments by Year
Investments by Region
VI Ventures Co-Investors (34)
| Name | With | Exits | Lead Partner | Series | Industry |
|---|---|---|---|---|---|
| Bristol-Myers Squibb | 1 |
|
|
||
| Farallon Capital Management |
|
|
|||
| Frazier Healthcare Partners |
|
|
|||
| Novo Holdings |
|
|
|||
| Piper Sandler |
|
|
VI Ventures FAQs
-
What is VI Ventures?
VI Ventures is a venture capital firm that seeks to invest in the Medtech and Technology, Media and Telecommunications sectors.
-
Where is VI Ventures headquartered?
VI Ventures is headquartered in Hong Kong, Hong Kong.
-
How many investments has VI Ventures made?
VI Ventures has made 56 investments.
-
What has VI Ventures invested in?
VI Ventures has made numerous investments in companies like AxCel Technology, Metagenomi, and Biovision Biomedical Technology within the Network Management Software, Drug Discovery, and Biotechnology industries.
-
What has VI Ventures invested in recently?
VI Ventures's latest investment was on 01-Mar-2023 in AxCel Technology, a company within the Network Management Software industry.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read blog » -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process »
